Digital Adherence Program
Program overview
This sponsored program aims to provide education and support to patients prescribed Testogel for the treatment of testosterone deficiency syndrome/Hypogonadism.
Patients will receive a series of 6 messages over 6 months aimed at improving their quality use of medicines, medication adherence and treatment outcomes.
When?
This program was launched in November 2017.
For which patients?
Messages will be delivered via the app and SMS to patients currently prescribed Testogel delivered in a pump.

© 2026 MedAdvisor International Pty Ltd